SCHEMBL19247015

SCHEMBL19247015

c1ccc(-c2nc(-n3c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc43)nc3c2oc2ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.39
MAPT P10636 8/20 0.37
KDM4E B2RXH2 5/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 4/20 0.36
POLB P06746 2/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 5/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MAPK1 P28482 2/20 0.36
CSF1R P07333 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ADORA2A P29274 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23874731 0.94 TSHR (0.38) TSHRMAPTKDM4EALDH1A1POLB
SCHEMBL19247011 0.91 ALDH1A1 (0.39) TSHRMAPTKDM4EATMALDH1A1
SCHEMBL20226383 0.91 TSHR (0.39) TSHRMAPTKDM4EALDH1A1POLB
SCHEMBL19246798 0.91 KDM4E (0.36) TSHRMAPTKDM4EATML3MBTL1
SCHEMBL19247088 0.91 MAPT (0.36) TSHRMAPTKDM4EATML3MBTL1
SCHEMBL25132231 0.90 CYP1A2 (0.35) TSHRMAPTKDM4EALDH1A1POLB
SCHEMBL26741214 0.89 KDM4E (0.34) TSHRKDM4EATML3MBTL1ALDH1A1
SCHEMBL17087599 0.89 KDM4E (0.38) TSHRMAPTKDM4EATML3MBTL1
SCHEMBL24839676 0.89 TSHR (0.39) TSHRMAPTKDM4EL3MBTL1ALDH1A1
SCHEMBL19246954 0.89 KDM4E (0.40) TSHRMAPTKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 TSHR 3601/4885MAPT 1277/4885KDM4E 4143/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 TSHR 3601/4885MAPT 1277/4885KDM4E 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.